Tag: Rubius Therapeutics Inc.

Tag Visualization: Top 50 related tags by occurrence

Recent Related Articles to Rubius Therapeutics Inc.

Qatar Fund Building Venture Capital Unit for US Startups

Added to Collection on: 2018-12-15 17:45:00

Tags for this article:

Business intelligence
ThoughtSpot
Qatar Investment Authority
Grail Inc.
ThoughtSpot Inc.
Foursquare Labs Inc.
Rubius Therapeutics Inc.
Homology Medicines Inc.

Click the tags to see associated articles and topics

View Article Details
1589798 Shares in Rubius Therapeutics Inc (RUBY) Purchased by BlackRock Inc.

Added to Collection on: 2019-01-16 20:22:30

Tags for this article:

YouTube
El Rubius
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
BlackRock Inc. Takes $38.16 Million Position in Rubius Therapeutics Inc (NASDAQ:RUBY)

Added to Collection on: 2019-01-23 22:15:00

Tags for this article:

Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Rubius Therapeutics Appoints Internationally Recognized Autoimmunity and Translational ...

Added to Collection on: 2020-01-07 20:56:15

Tags for this article:

Life Sciences
Biology
Biotechnology
Cell therapy
Autoimmune disease
Immunotherapy
Biopharmaceutical
Rheos
Laurence Turka
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Estimates could be Right: Rubius Therapeutics Inc. (RUBY), Activision Blizzard Inc. (ATVI)

Added to Collection on: 2020-12-16 20:26:15

Tags for this article:

Financial markets
Finance
Money
Stock market
Video game publishers
Corporate finance
Financial ratios
Activision Blizzard
Blizzard Entertainment
ATVI
Stock
Activision
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Rubius Therapeutics Reports Initial Clinical Data from Ongoing Phase 1/2 Trial of RTX-240 in ...

Added to Collection on: 2021-03-15 11:37:30

Tags for this article:

Clinical medicine
Medicine
Branches of biology
Lymphocytes
Immune system
Eye color
Melanoma
Uveal melanoma
Treatment of cancer
Natural killer cell
Tumor microenvironment
Cancer immunotherapy
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Rubius Therapeutics Announces Proposed Public Offering of Common Stock

Added to Collection on: 2021-03-15 20:26:15

Tags for this article:

Initial public offering
Financial markets
Financial economics
Finance
Money
U.S. Securities and Exchange Commission
SEC filings
Communication
Forward-looking statement
Prospectus
Shelf registration
Public offering
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
BitMEX Co-Founder Arthur Hayes Offers to Surrender to US Authorities in Hawaii

Added to Collection on: 2021-03-17 10:25:14

Tags for this article:

Companies
Pharmaceutical companies
Life Sciences
Economy of New York City
NASDAQ
AstraZeneca
Johnson & Johnson
Amneal Pharmaceuticals
Genmark Diagnostics Inc
Sotera Health Company
Champions Oncology Inc.
Organogenesis Holdings Inc.
Omnicell Inc.
Moderna
Solid Biosciences
Roche Holding AG
Aerie Pharmaceuticals Inc.
Renalytix AI plc
BioCryst Pharmaceuticals Inc.
Rubius Therapeutics Inc.
IDEAYA Biosciences Inc.
Samples Fulgent Genetics Inc.
Amneal Pharmaceuticals Inc.
Vincerx Pharma Inc.
Gemini Therapeutics Inc.
Silverback Therapeutics Inc.
FULGENT GENETICS
Harvard Bioscience Inc.
Aclaris Therapeutics Inc.
Prometheus Biosciences Inc.
Axonics Modulation Technologies Inc.
Oncternal Therapeutics Inc.
GENOMIC
Galecto Inc.
AngioDynamics Inc.
Elanco Animal Health Incorporated

Click the tags to see associated articles and topics

View Article Details
Euclidean Capital LLC Buys Beam Therapeutics Inc, Vir Biotechnology Inc, Pinduoduo Inc, Sells ...

Added to Collection on: 2021-06-16 16:30:00

Tags for this article:

Financial economics
Finance
Corporate finance
Stock
Stock market
Money
Pinduoduo
Rubius Therapeutics Inc.
Vir Biotechnology Inc.
ORIC Pharmaceuticals Inc
Pinduoduo Inc
Beam Therapeutics Inc

Click the tags to see associated articles and topics

View Article Details
Brokerages Anticipate Rubius Therapeutics, Inc. (NASDAQ:RUBY) to Post -$0.51 EPS

Added to Collection on: 2021-06-21 15:11:15

Tags for this article:

Finance
Corporate finance
Financial ratios
Financial markets
Money
Fundamental analysis
Stock market
Price?earnings ratio
Earnings per share
Stock
ANGI Homeservices
Rubius Therapeutics Inc.

Click the tags to see associated articles and topics

View Article Details
Book a Demo